Global Information Lookup Global Information

Chiesi Farmaceutici information


Chiesi Farmaceutici
Company typeSocietà per Azioni, (S.p.A.)
(something like a Joint-Stock company)
IndustryPharmaceuticals
Founded1935
Headquarters
Parma
,
Italy
Key people
Alberto Chiesi (President)
Paolo Chiesi (Vice-president)
Giuseppe Accogli(CEO)
Revenue€3 billion (2023)
Number of employees
6500
Websitewww.chiesi.com

Chiesi Farmaceutici S.p.A. is an Italian family controlled[1][2] global pharmaceutical company based in Parma, Emilia-Romagna. Chiesi has 31 affiliates[3] in the world, nearly 6,500 total employees[4] and provides medicines to patients in 100 nations. Chiesi currently has revenues of 3 billion euros.[4] According to 2020 official data from the European Patent Office (EPO), Chiesi Group, with 42 patents filed, is confirmed as the first Italian Pharmaceutical Company and third among Italian Companies across all sectors for filing the highest number of patents.[5]

In June 2019, Chiesi became a certified B Corporation, thus choosing to adopt a new legal status under US and Italian law. This ensures Chiesi legal protection to pursue a business model placing social and environmental values on equal footing with profits.[6]

Following the acquisition, in 1999, of Huddersfield based Trinity Pharmaceuticals, Chiesi has also had a significant presence in Manchester, United Kingdom.[7]

  1. ^ In July 2014 the company website shows a Consiglio di Amministrazione (Board of Directors) comprising eight individuals. Six of these are named "Chiesi"
  2. ^ "Chiesi Farmaceutici S.p.A." chiesigroup.com.
  3. ^ "Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification". Bloomberg.com. Bloomberg L.P. 6 June 2019. Retrieved 2019-07-08.
  4. ^ a b "Chiesi Annual report 2019". chiesi.com. Retrieved 2019-07-08.
  5. ^ Office, European Patent. "Statistics". www.epo.org. Retrieved 2021-04-01.
  6. ^ "Chiesi Group | Certified B Corporation". bcorporation.net. Retrieved 2019-07-08.
  7. ^ "Chiesi UK - About Chiesi". www.chiesi.uk.com. Retrieved 2024-06-12.

and 10 Related for: Chiesi Farmaceutici information

Request time (Page generated in 0.7619 seconds.)

Chiesi Farmaceutici

Last Update:

Chiesi Farmaceutici S.p.A. is an Italian family controlled global pharmaceutical company based in Parma, Emilia-Romagna. Chiesi has 31 affiliates in the...

Word Count : 1143

Poractant alfa

Last Update:

is a pulmonary surfactant sold under the brand name Curosurf by Chiesi Farmaceutici. Poractant alfa is an extract of natural porcine lung surfactant...

Word Count : 583

List of benefit corporations

Last Update:

Cabot Creamery Care2 Cariuma Carrot Rewards Casebook PBC Change.org Chiesi Farmaceutici Corporate Knights CostPlus Drugs Danone North America Ecosia EcoZoom...

Word Count : 185

Parma

Last Update:

players in this sector include Barilla, which is based in the city. Chiesi Farmaceutici, in the pharma industry, is headquartered in Parma. The European...

Word Count : 4060

Gene therapy

Last Update:

Archived from the original on 5 November 2012. Retrieved 2 January 2022. "Chiesi and uniQure delay Glybera launch to add data". Biotechnology. The Pharma...

Word Count : 17853

Pegunigalsidase alfa

Last Update:

treatment of Fabry disease. The applicant for this medicinal product is Chiesi Farmaceutici S.p.A. Elfabrio was approved for medical use in the European Union...

Word Count : 416

List of companies of Italy

Last Update:

instruments Chicco Consumer goods Toys Como 1958 Children's items and toys Chiesi Farmaceutici S.p.A. Health care Pharmaceuticals Parma 1935 Pharmaceuticals Cinelli...

Word Count : 602

Alipogene tiparvovec

Last Update:

Europe to Chiesi Farmaceutici for €31 million. As of 2016, only one person had received the drug outside of a clinical trial. In April 2017, Chiesi quit selling...

Word Count : 1171

Carmoterol

Last Update:

1476-5381.2011.01216.x. PMC 3085864. PMID 21232045. "Chiesi: Annual Report 2010" (PDF). Chiesi Farmaceutici S.p.A. p. 20. Retrieved 27 March 2016. Donohue JF...

Word Count : 220

Corporate responses to the Russian invasion of Ukraine

Last Update:

humanitarian needs of the people of Ukraine. Chiesi Farmaceutici Pharmaceuticals  Italy $1,090,000 $1,090,000 Chiesi announced an initial donation of one million-euro...

Word Count : 10254

PDF Search Engine © AllGlobal.net